Helicos BioSciences

company

About

Helicos BioSciences Corporation (Helicos) is a life sciences company, which has developed technology focused on the research, drug

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$40M
Industries
Biotechnology,Genetics,Health Diagnostics,Life Science
Founded date
Jan 1, 2003
Number Of Employee
11 - 50
Operating Status
Close

Helicos BioSciences Corporation (Helicos) is a life sciences company, which has developed technology focused on the research, drug discovery and clinical diagnostics markets. Its True Single Molecule Sequencing (tSMS) technology enables rapid analysis of large quantities of genetic material by directly sequencing single molecules of deoxyribonucleic acid (DNA) or single DNA copies of ribonucleic acid (RNA) (cDNA) and its approach of direct sequencing of RNA. Its Helicos Genetic Analysis Platform is designed to obtain sequencing information by repetitively performing a cycle of biochemical reactions on individual DNA or RNA molecules and imaging the results after each cycle. The platform consists of an instrument called the HeliScope Single Molecule Sequencer, an image analysis computer tower called the HeliScope Analysis Engine, associated reagents, which are chemicals used in the sequencing process and disposable supplies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$77M
Helicos BioSciences has raised a total of $77M in funding over 2 rounds. Their latest funding was raised on Feb 1, 2012 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2012 Series A $27M 1 Detail
Sep 28, 2009 Post-IPO Equity $10M 1 Detail
Mar 15, 2006 Series B $40M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Helicos BioSciences is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series A